Compare
Arcadia Biosciences, Inc. vs Viking Global Technologies, Inc. vs Indonesia Energy Corp Ltd vs Royale Energy, Inc.
| Latest fiscal year | Arcadia Biosciences, Inc. RKDA | Viking Global Technologies, Inc. CEIN | Indonesia Energy Corp Ltd INDO | Royale Energy, Inc. ROYL |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $4.86M | $6.23M | $2.01M | $1.95M |
| Revenue growth (YoY) | -3.7% | -78.2% | -24.6% | -13.9% |
| Gross margin | 36.2% (computed) | 25.4% (computed) | n/a | n/a |
| Operating margin | -51.5% | -127.6% | -227.5% | -46.9% |
| Net margin | -48.1% | -70.8% | -253.2% | -64.3% |
| Net income | -$2.34M | -$4.41M | -$5.10M | -$1.25M |
| EPS (Diluted) | -$1.71 | -$0.02 | -$0.35 | -$0.01 |
| Operating cash flow | -$4.74M | -$2.33M | -$5.43M | -$2.70M |
| Free cash flow | -$4.74M | -$2.34M | -$5.48M | -$4.20M |
| Cash & equivalents | $259.0K | n/a | $0 | $1.10M |
| Total assets | $6.55M | $19.84M | $22.76M | $17.00M |
| Total liabilities | $2.41M | $63.21M | $3.10M | $30.39M |
| Shareholders' equity | $4.14M | -$49.77M | $19.66M | -$13.39M |
| Return on year-end equity | -56.5% | n/a | -25.9% | n/a |
| Shares outstanding | 1.37M | 281.69M | 14.99M | 96.60M |
Revenue, most recent five fiscal years
| Fiscal year | Arcadia Biosciences, Inc. | Viking Global Technologies, Inc. | Indonesia Energy Corp Ltd | Royale Energy, Inc. |
|---|---|---|---|---|
| Latest | $4.86M Ended 2025-12-31 | $6.23M Ended 2025-12-31 | $2.01M Ended 2025-12-31 | $1.95M Ended 2025-12-31 |
| 1 year earlier | $5.04M Ended 2024-12-31 | $28.61M Ended 2024-12-31 | $2.67M Ended 2024-12-31 | $2.26M Ended 2024-12-31 |
| 2 years earlier | $4.45M Ended 2023-12-31 | $32.05M Ended 2023-12-31 | $3.53M Ended 2023-12-31 | $2.16M Ended 2023-12-31 |
| 3 years earlier | $7.42M Ended 2022-12-31 | $24.04M Ended 2022-12-31 | $4.10M Ended 2022-12-31 | $2.64M Ended 2022-12-31 |
| 4 years earlier | $6.78M Ended 2021-12-31 | $401.2K Ended 2021-12-31 | $2.45M Ended 2021-12-31 | $1.72M Ended 2021-12-31 |